Literature DB >> 22395348

Indications for surgery and significance of unrecognized cancer in endemic multinodular goiter.

Konstantinos Lasithiotakis1, Evangelia Grisbolaki, Dimosthenis Koutsomanolis, Maria Venianaki, Ioannis Petrakis, Nikolaos Vrachassotakis, Emanuel Chrysos, Odysseas Zoras, George Chalkiadakis.   

Abstract

BACKGROUND: The exclusion of cancer in endemic goiter is often difficult mainly because of the high number of nodules and the as-yet unclear natural history of diagnosed cancer in endemic goiter patients. In a large number of consecutive patients who were to undergo total thyroidectomy for endemic multinodular goiter, we assessed indications for surgery and thyroid cancer outcome.
METHODS: All patients who were to undergo total thyroidectomy for diffuse multinodular goiter on histological examination between January 1990 and October 2008 were evaluated.
RESULTS: Of the 1,161 patients included in the study, 252 were cases of thyroid cancer (21.7%). Sensitivity of thyroid ultrasound (US) and fine-needle aspiration cytology (FNAC) for cancer detection was 30.3 and 64.1%, respectively. Differentiated thyroid carcinoma accounted for most of the tumors (96%), with 54.8% of them being papillary microcarcinomas, while bilateral-multicentric cancer occurred in 20.3%. In multivariate analysis, younger age (p = 0.06), sonographic findings (p = 0.03), and presence of histological thyroiditis (p = 0.09) were independently associated with the occurrence of tumors with diameter greater than 2 cm. The percentage of transient and permanent postoperative complications were approximately 25 and below 2%, respectively. After a median follow-up time of 78.5 months, overall recurrence rate was 6.7% and disease-specific mortality was 1.2%.
CONCLUSION: As US and FNAC did not consistently detect cancer in patients with diffuse multinodular goiter in our endemic area, evidence-based indications for surgery in this group of patients is needed, although radical surgery and favorable tumor histology offer favorable outcomes in commonly diagnosed thyroid cancer after total thyroidectomy for endemic multinodular goiter.

Entities:  

Mesh:

Year:  2012        PMID: 22395348     DOI: 10.1007/s00268-012-1554-8

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  31 in total

Review 1.  Drug-induced osteoporosis: mechanisms and clinical implications.

Authors:  Gherardo Mazziotti; Ernesto Canalis; Andrea Giustina
Journal:  Am J Med       Date:  2010-10       Impact factor: 4.965

Review 2.  Radioiodine for nontoxic multinodular goiter.

Authors:  D Huysmans; A Hermus; M Edelbroek; J Barentsz; F Corstens; P Kloppenborg
Journal:  Thyroid       Date:  1997-04       Impact factor: 6.568

Review 3.  Benign multinodular goiter.

Authors:  A Frilling; C Liu; F Weber
Journal:  Scand J Surg       Date:  2004       Impact factor: 2.360

4.  Recent advances in thyroid cancer.

Authors:  Elizabeth G Grubbs; Thereasa A Rich; Guojun Li; Erich M Sturgis; Maher N Younes; Jeffrey N Myers; Beth Edeiken-Monroe; Bruno D Fornage; Douglas P Monroe; Gregg A Staerkel; Michelle D Williams; Steven G Waguespack; Mimi I Hu; Gilbert Cote; Robert F Gagel; James Cohen; Randal S Weber; Daniel A Anaya; F Chris Holsinger; Nancy D Perrier; Gary L Clayman; Douglas B Evans
Journal:  Curr Probl Surg       Date:  2008-03       Impact factor: 1.909

5.  Fine-needle aspiration biopsy of thyroid nodules: experience in a cohort of 944 patients.

Authors:  Nina D Baier; Peter F Hahn; Debra A Gervais; Anthony Samir; Elkan F Halpern; Peter R Mueller; Mukesh G Harisinghani
Journal:  AJR Am J Roentgenol       Date:  2009-10       Impact factor: 3.959

6.  LigaSure versus clamp-and-tie thyroidectomy for benign nodular disease.

Authors:  Ioannis E Petrakis; Nektarios E Kogerakis; Kostas G Lasithiotakis; Nikolaos Vrachassotakis; Georgios E Chalkiadakis
Journal:  Head Neck       Date:  2004-10       Impact factor: 3.147

7.  Differences between endocrine surgeons and endocrinologists in the management of non-toxic multinodular goitre.

Authors:  M C Bhagat; S S Dhaliwal; S J Bonnema; L Hegedüs; J P Walsh
Journal:  Br J Surg       Date:  2003-09       Impact factor: 6.939

8.  Recurrence of goitre after operation in euthyroid patients.

Authors:  S Piraneo; P Vitri; A Galimberti; S Guzzetti; A Salvaggio; A Bastagli
Journal:  Eur J Surg       Date:  1994 Jun-Jul

9.  Incidental and nonincidental papillary thyroid microcarcinoma.

Authors:  Jen-Der Lin; Sheng-Fong Kuo; Tzu-Chieh Chao; Chuen Hsueh
Journal:  Ann Surg Oncol       Date:  2008-05-16       Impact factor: 5.344

Review 10.  Treatment and prevention of recurrence of multinodular goiter: an evidence-based review of the literature.

Authors:  Jacob Moalem; Insoo Suh; Quan-Yang Duh
Journal:  World J Surg       Date:  2008-07       Impact factor: 3.352

View more
  4 in total

1.  The gold standard of thyroid nodule examination? Prospective validation of the ACR TI-RADS in a secondary referral center.

Authors:  T Grimmichová; P Pačesová; L Srbová; J Vrbíková; T Havrdová; M Hill
Journal:  Physiol Res       Date:  2020-09-30       Impact factor: 1.881

Review 2.  Non-Toxic Multinodular Goiter: From Etiopathogenesis to Treatment.

Authors:  Mehmet Taner Unlu; Mehmet Kostek; Nurcihan Aygun; Adnan Isgor; Mehmet Uludag
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2022-03-28

3.  Positive central lymph-nodes are underdiagnosed in patients with Bethesda V cytology in an endemic goiter region.

Authors:  Lindsay Hargitai; Stephanie Strobl; Oskar Koperek; Susanne Urach; Wolfgang Raber; Anton Staudenherz; Christian Scheuba; Philipp Riss
Journal:  Gland Surg       Date:  2020-04

4.  Should the Prevalence of Incidental Thyroid Cancer Determine the Extent of Surgery in Multinodular Goiter?

Authors:  Krzysztof Kaliszewski; Marta Strutyńska-Karpińska; Agnieszka Zubkiewicz-Kucharska; Beata Wojtczak; Paweł Domosławski; Waldemar Balcerzak; Tadeusz Łukieńczuk; Zdzisław Forkasiewicz
Journal:  PLoS One       Date:  2016-12-22       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.